These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 3892345)
1. Serum potassium concentrations in cyclosporine- and azathioprine-treated renal transplant patients. Foley RJ; Hamner RW; Weinman EJ Nephron; 1985; 40(3):280-5. PubMed ID: 3892345 [TBL] [Abstract][Full Text] [Related]
2. Hyperchloremic metabolic acidosis with high serum potassium in renal transplant recipients: a cyclosporine A associated side effect. Stahl RA; Kanz L; Maier B; Schollmeyer P Clin Nephrol; 1986 May; 25(5):245-8. PubMed ID: 3521998 [TBL] [Abstract][Full Text] [Related]
3. 'Nephrotoxicity' and metabolic acidosis in transplant patients on cyclosporin A. Hamilton DV; Evans DB; Henderson RG; Thiru S; Calne RY; White DJ; Carmichael DJ Proc Eur Dial Transplant Assoc; 1981; 18():400-9. PubMed ID: 7036160 [TBL] [Abstract][Full Text] [Related]
4. A prospective randomized trial of pretransfusion/azathioprine/prednisone versus cyclosporine/prednisone immunosuppression in cardiac transplant recipients: preliminary results. Barnhart GR; Hastillo A; Goldman MH; Szentpetery S; Wolfgang TC; Mohanakumar T; Katz MR; Rider S; Hanrahan J; Lower RR Circulation; 1985 Sep; 72(3 Pt 2):II227-30. PubMed ID: 3896555 [TBL] [Abstract][Full Text] [Related]
5. Hypomagnesemia and renal magnesium wasting in renal transplant recipients receiving cyclosporine. Barton CH; Vaziri ND; Martin DC; Choi S; Alikhani S Am J Med; 1987 Oct; 83(4):693-9. PubMed ID: 3314493 [TBL] [Abstract][Full Text] [Related]
6. Renal function and lipid metabolism in pregnant renal transplant recipients. Czajkowski K; Wójcicka-Bentyn J; Sieńko J; Grymowicz M; Smolarczyk R; Malinowska-Polubiec A; Romejko E Eur J Obstet Gynecol Reprod Biol; 2004 Jun; 114(2):155-61. PubMed ID: 15140508 [TBL] [Abstract][Full Text] [Related]
7. Effects of cyclosporine on the renin-angiotensin-aldosterone system and potassium excretion in renal transplant recipients. Bantle JP; Nath KA; Sutherland DE; Najarian JS; Ferris TF Arch Intern Med; 1985 Mar; 145(3):505-8. PubMed ID: 3883934 [TBL] [Abstract][Full Text] [Related]
8. Cyclosporine-induced changes in glomerular filtration rate and urea excretion. Laskow DA; Curtis JJ; Luke RG; Julian BA; Jones P; Deierhoi MH; Barber WH; Diethelm AG Am J Med; 1990 May; 88(5):497-502. PubMed ID: 2337107 [TBL] [Abstract][Full Text] [Related]
9. Serum propeptides of type I and III procollagens in renal transplant recipients. A comparison of cyclosporine and azathioprine treatment. Heickendorff L; Frost L; Madsen JK; Pedersen EB Nephron; 1994; 67(2):203-8. PubMed ID: 8072610 [TBL] [Abstract][Full Text] [Related]
10. Apoenzyme content of serum aminotransferases in patients with a renal allograft treated with cyclosporine A and azathioprine. Hafkenscheid JC; Rosier JG; van Dijk CM Clin Chim Acta; 1987 May; 165(1):21-5. PubMed ID: 3301076 [TBL] [Abstract][Full Text] [Related]
11. Cyclosporine-induced hyperuricemia and gout. Lin HY; Rocher LL; McQuillan MA; Schmaltz S; Palella TD; Fox IH N Engl J Med; 1989 Aug; 321(5):287-92. PubMed ID: 2664517 [TBL] [Abstract][Full Text] [Related]
12. Cyclosporine, azathioprine, and prednisone as treatment for cyclosporine-induced nephrotoxicity in renal transplant recipients. Lorber MI; Flechner SM; Van Buren CT; Kerman RH; Kahan BD Transplant Proc; 1985 Aug; 17(4 Suppl 1):282-5. PubMed ID: 3895668 [No Abstract] [Full Text] [Related]
13. Cyclosporine nephrotoxicity and early posttransplant hyperkalemia in living-donor renal recipients: report of 4 cases. Pavleska-Kuzmanovska S; Popov Z; Ivanovski O; Ristovska V; Masin-Spasovska J; Rambabova-Busljetic I; Ivanovski N Exp Clin Transplant; 2014 Oct; 12(5):479-83. PubMed ID: 24417207 [TBL] [Abstract][Full Text] [Related]
14. [Kaposi's sarcoma in kidney transplant treated with cyclosporin and azathioprine]. Cózar JM; Martínez Piñeiro L; Avellana JA; de la Peña J; Hidalgo L; Sanz A; Burgos F; Martínez Piñeiro JA Arch Esp Urol; 1990 Mar; 43(2):155-8. PubMed ID: 2363579 [TBL] [Abstract][Full Text] [Related]
15. Hyperkalaemia in cyclosporin-treated renal allograft recipients. Adu D; Turney J; Michael J; McMaster P Lancet; 1983 Aug; 2(8346):370-2. PubMed ID: 6135874 [TBL] [Abstract][Full Text] [Related]
16. Influence of cyclosporine on posttransplant blood pressure response. Jarowenko MV; Flechner SM; Van Buren CT; Lorber MI; Kahan BD Am J Kidney Dis; 1987 Aug; 10(2):98-103. PubMed ID: 3300297 [TBL] [Abstract][Full Text] [Related]
17. Effects of H2-receptor antagonists on renal function in cyclosporine-treated renal transplant patients. Pachon J; Lorber MI; Bia MJ Transplantation; 1989 Feb; 47(2):254-9. PubMed ID: 2645708 [TBL] [Abstract][Full Text] [Related]
18. Is cyclosporine A-induced nephrotoxicity in recipients of renal allografts progressive? Thiel G; Mihatsch M; Landmann J; Hermle M; Brunner FP; Harder F Transplant Proc; 1985 Aug; 17(4 Suppl 1):169-78. PubMed ID: 3895657 [No Abstract] [Full Text] [Related]
19. Epidermal dysplasia and cyclosporine therapy in renal transplant patients: a comparison with azathioprine. Shuttleworth D; Marks R; Griffin PJ; Salaman JR Br J Dermatol; 1989 Apr; 120(4):551-4. PubMed ID: 2525045 [TBL] [Abstract][Full Text] [Related]